Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Demographic Characteristics of Adult Patients With NEurofibromatosis in RUSsia

NCT07088991 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07088991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Demographic Characteristics of Adult Patients With NEurofibromatosis in RUSsia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2025
Completion date
March 31, 2028
Enrollment
200 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis